Navigation Links
New Ray of Hope for HIV Patients
Date:11/9/2012

BANGALORE, November 9, 2012 /PRNewswire/ --

DNA Gene Therapy for Degenerative Diseases

In today's reality, terms like genetic engineering and gene therapy have become facts which prophets of science had only dreamt about few years ago. Pain, disability and disease have long plagued mankind, medicine has long sought its answers, research and development are yet uncovering labyrinths of technology to reach to a panacea.

Dr.Agarwal Hospitals nestled in bubbling Bangalore has brought out a customized version of GENE THERAPY where the patient's own peripheral capillary blood (one drop) is taken as the raw stock admixed with Mana (DNA activator) it brings back healthy or fetal DNA of the same patient. This is then used as injections to the same patient within seconds of the mixture. A course of ten injections is given over a span of one week to ten days bringing about a healthy change in the patients course of disease.

Over 20 years of research conducted by Dr.Agarwal Hospitals on genetic engineering, where last 8 years have been spent on treating over 12000 patients through variety of illness in different stages of disease has brought new hope to mankind.

Mana (DNA activator) a propriety formula is taken in a syringe and customized with a drop of the patient's blood. This forms the patients healthy DNA in vitro and is given back to the patient as sub cutaneous injections over a period of ten days every month for severe conditions.

Mana is a DNA activator - proven to recreate patients own healthy DNA  

When Mana & Plasma are mixed within the first second healthy DNA strands start amplifying (proven through research and validation)

It's the patient's own DNA being given back : No Side Effects

Dr.Sunita Rana Agarwal, Chief Scientist, Dr Agarwal Hospitals & Gene Research Foundation, carried out the research in this field on patients who were HIV positive. The CD4 ratio counts varied from 186 to 35
'/>"/>

SOURCE Dr.Agarwal Hospitals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DioGenix MSPrecise Identifies Early-Stage Patients with Multiple Sclerosis
2. Multimodal Treatment of Peritoneal Metastases Offers Hope for Many Patients With Colorectal Cancer
3. Stem Cells Bring New Hope for Parry-Romberg Syndrome Patients
4. Sosei Group Corporation QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients and Filings in EU and Japan by End of Year
5. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
6. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
7. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
8. Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
9. New Findings of Daily Consumption of Soy Isoflavones and Cacao-Flavonoids in Diabetes Type 2 Patients
10. New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy
11. Prioritizing lab testing for patients on antiretroviral treatment in resource-constrained settings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... is pleased to announce that the Company will be ... 2015 to be held in London, UK ... and Mr. James Mellon , a director of ... the key programs at its subsidiaries, Portage Pharmaceuticals Ltd. ...
(Date:4/16/2015)... MOSCOW , April 16, 2015 /PRNewswire/ ... (ChemRar), the Russian pharmaceutical investment and R&D ... announced collaboration for research, development and commercialization ... with the intention to stimulate ... industry.      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     ...
(Date:4/16/2015)... Calif. , April 16, 2015  Scientists from ... "New Drugs on the Horizon," at the American Association ... Philadelphia, PA on Sunday, April 19, 2015 ... Ph.D., Cleave,s Director of Biology, will present new in ... a first-in-class, oral inhibitor of p97, a critical enzyme ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3
... 7 /PRNewswire-FirstCall/ - Oncothyreon Inc. (the,"Company") (Nasdaq: ... development of innovative therapeutic products for the treatment ... its fourth quarter and,full year 2007 financial results ... the U.S. and Canadian markets. Following the release, ...
... Corporation,(Nasdaq: ACEL ) today reported its financial results ... recorded a net loss of approximately $1.7 million, or ... fiscal quarter ended,Jan. 31, compared to a net loss ... share, for the second quarter of fiscal 2007. The ...
... PARK, Ill., March 7 Abbott (NYSE: ... Annual Global Healthcare,Conference on Tuesday, March 18, 2008. ... financial officer, will make a formal,presentation on the ... live audio webcast of the presentation will be ...
Cached Biology Technology:Alfacell Reports Financial Results for Second Quarter of Fiscal 2008 2Alfacell Reports Financial Results for Second Quarter of Fiscal 2008 3Alfacell Reports Financial Results for Second Quarter of Fiscal 2008 4Alfacell Reports Financial Results for Second Quarter of Fiscal 2008 5
(Date:4/13/2015)... YORK , April 13, 2015 ... by TechSci Research, "Global Biometrics Market Forecast & Opportunities, ... register a CAGR of around 14% till 2020. ... governments for large scale implementation and review of ... and launch of new products with greater efficiency, ...
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/143028 for MINIATURE, MULTI-PURPOSE ... TRANSFER  NXT-ID introduces a new revolutionary ... patent surrounds the use of miniature antenna modules ...
(Date:4/1/2015)... OXFORD, Conn. , Apr. 1, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... number of Wocket smart wallets is underway to early ... early access group includes usage at retail outlets including ... CVS Pharmacy. Users report Wocket was accepted at all ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... immune response in the eyes of freshwater fishes has created ... in the journal Molecular Ecology . The study provides ... that parasitize Canadian fish. "Canada probably has the best ... amazed when we found four times more species of flukes ...
... three decades, oceanographers have been puzzled by the ability of ... very little nitrate, an essential algal nutrient. In this week,s ... along with coauthors Stephen Riser at the University of Washington ... mid-ocean algae obtain nitrate from deep water, as much as ...
... Md., June 24, 2010 The National Science Foundation ... to the American Society for Biochemistry and Molecular Biology ... across the nation. The initiative aims to improve ... foundational concepts and skills for the discipline and by ...
Cached Biology News:Adaptation is (not) in the eye of the beholder 2Researchers discover source of essential nutrients for mid-ocean algae 2Researchers discover source of essential nutrients for mid-ocean algae 3NSF grant will develop new online hub for biochemistry, molecular biology educators 2
Includes a choice of any 3 EasySep mouse selection kits and EasySep magnet...
... 1.5mg of purified RNA samples., , This ... of aqueous RNA samples that have been ... phenol/chloroform, silica, oligo dT etc or other ... the necessary components for the stabilization of ...
Human SEAP ORF, provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
Biology Products: